Cite

HARVARD Citation

    Steinemann, G. et al. (2019). Antitumor and antiangiogenic activity of the novel chimeric inhibitor animacroxam in testicular germ cell cancer. Molecular oncology. 13 (12), pp. 2679-2696. [Online]. 
  
Back to record